Ignite Creation Date:
2024-05-06 @ 9:56 AM
Last Modification Date:
2024-10-26 @ 12:22 PM
Study NCT ID:
NCT03116529
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-09-13
First Post:
2017-04-12
Brief Title:
Neoadjuvant Durvalumab and Tremelimumab Plus Radiation for High Risk Soft-Tissue Sarcoma
Sponsor:
University of Maryland Baltimore
Organization:
University of Maryland Baltimore
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-06-21
Start Date Type:
ACTUAL
Primary Completion Date:
2032-06-21
Primary Completion Date Type:
ESTIMATED
Completion Date:
2037-06-21
Completion Date Type:
ESTIMATED
First Submit Date:
2017-04-12
First Submit QC Date:
April 14 2017
Study First Post Date:
2017-04-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-09-11
Last Update Post Date:
2023-09-13
Last Update Post Date Type:
ACTUAL